Edition:
United States

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

9.80USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$9.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,857
52-wk High
$11.55
52-wk Low
$5.90

Chart for

About

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies,... (more)

Overall

Beta: 1.28
Market Cap(Mil.): $136.78
Shares Outstanding(Mil.): 14.17
Dividend: --
Yield (%): --

Financials

  CEMI.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -0.38 -- --
ROI: -25.78 13.18 12.83
ROE: -26.54 15.14 14.95

BRIEF-Chembio Diagnostics Reports Q1 Loss Per Share $0.05

* CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

Apr 25 2018

Competitors

Earnings vs. Estimates